Back

The impact of very highly elevated lipoprotein(a) levels on the early onset, complexity, and extent of coronary artery disease

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Lipid-lowering and inflammation Angiography, Invasive Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Mr Casper Coerkamp

Amsterdam (Netherlands (The))

7 More presentations in this session

Presentation thumbnail
Association of colchicine with cardiovascular outcomes in patients with acute coronary syndrome
Doctor M. Tao (Hartford, US)
Abstract Slides Video
Presentation thumbnail
Non-steroidal anti-inflammatory drug use after invasive and non-invasive diagnostic procedures for coronary artery disease by the degree of disease: a Danish drug utilization study (2008-2021)
Doctor A. Bech-Drewes (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Healed plaque and systemic thrombogenicity in patients with chronic coronary syndrome
Doctor D. Kinoshita (Yamagata, JP)
Abstract Slides Video
Presentation thumbnail
Effects of vitamin k2 and d3 supplementation on cardiac and systemic inflammation: a randomized controlled trial
Doctor S. Hasific (Odense, DK)
Abstract Slides Video
Presentation thumbnail
Emerging role of inflammatory pathways on coronary atherosclerotic risk in patients with chronic coronary syndromes under current treatment
Doctor C. Caselli (Pisa, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Lipid-lowering and inflammation

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Relation of Lp(a) with plaque characteristics and clinical events: ATHEROREMO and IBIS_3 cohorts
thumbnail
Congress Presentation
Lipoprotein(a) measurements identify patients with elevated likelihood of obstructive coronary artery disease despite very low or low clinical likelihood
thumbnail
Congress Presentation
Lipoprotein(a) levels in acute coronary syndrome: analysis of sex, age, and cardiovascular risk factors

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources